| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/28/2002 | US6395496 Method and kit for evaluating the metastatic tendency of tumors |
| 05/28/2002 | US6395495 Methods and kits for detecting antibodies against an HIV variant |
| 05/28/2002 | US6395494 Method to determine TGF-β |
| 05/28/2002 | US6395490 Detecting viral infection in plants; obtain sample, incubate with viral probe, detect hybridization signal, presence of signal indicates that virus infection |
| 05/28/2002 | US6395484 Generating culture of preferential proteins; obtain cells; transform cells, recover genetically engineered cells, recover preferentially expressed polypeptides |
| 05/28/2002 | US6395477 Human potassium channel polynucleotide and polypeptides and uses thereof |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395471 Expression vector coding preferential polypeptides for use in diagnostic screening of viricides |
| 05/28/2002 | US6395306 For rheumatoid arthritis |
| 05/28/2002 | US6395278 Prostate specific fusion protein compositions |
| 05/28/2002 | US6395276 Killing malignant b cells by contacting with protein having ribonuclease activity linked to antibody against b cell surface marker; anticancer agents |
| 05/28/2002 | US6395274 Administering murine anti-human interleukin-5 monoclonal antibody, binding fragment or chimeric binding molecule to human to modulate inflammation; antiinflammatory agents |
| 05/28/2002 | US6395272 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | US6394975 Method to apply compositions to a surface |
| 05/28/2002 | CA2248006C Activated linkers and methods for making and purifying the same |
| 05/28/2002 | CA2240795C Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2104780C Lipid fractionation |
| 05/28/2002 | CA2092533C Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 05/28/2002 | CA2071651C A parenterally administrable drug having thrombolytic activity and containing protein c |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/28/2002 | CA1341363C Insulinotropic hormone |
| 05/28/2002 | CA1341362C Human manganese superoxide dismutase cdna, its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase |
| 05/23/2002 | WO2002040720A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040719A2 Retinoid pathway assays, and compositions therefrom |
| 05/23/2002 | WO2002040718A2 Method to identify genes associated with chronic myelogenous leukemia |
| 05/23/2002 | WO2002040713A1 Nucleic acids for detecting fungi belonging to the genus candida and method of detecting fungi belonging to the genus candida by using the same |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040695A1 Method for mass-producing human ferritin using recombinant nethylotropic yeasts |
| 05/23/2002 | WO2002040692A2 Specific promoter of the human vascular endothelial cadherin-2 (hve-cad-2) gene and the therapeutic uses thereof |
| 05/23/2002 | WO2002040691A2 Strawberry vein banding virus (svbv) promoter |
| 05/23/2002 | WO2002040688A2 Maize yellow stripe1 and related genes |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040680A2 Death domain proteins |
| 05/23/2002 | WO2002040679A2 Corynebacterium glutamicum promoters |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040675A1 Novel human tumor necrosis factor mutant proteins and their preparing methods and uses |
| 05/23/2002 | WO2002040674A2 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/23/2002 | WO2002040673A2 Compositions and methods relating to lung specific genes and proteins |
| 05/23/2002 | WO2002040672A2 Compositions and methods relating to breast specific genes and proteins |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040670A2 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain |
| 05/23/2002 | WO2002040669A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37 |
| 05/23/2002 | WO2002040668A2 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 05/23/2002 | WO2002040667A1 Method of diagnosing and treating lesion of crystalline lens using human crygs gene and coding product thereof |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040662A2 Transgenic mice containing targeted gene disruptions |
| 05/23/2002 | WO2002040661A2 TRANSGENIC MICE CONTAINING Kir2.3 POTASSIUM K+ CHANNEL GENE DISRUPTIONS |
| 05/23/2002 | WO2002040656A2 47476, 67210, 49875, 46842, 33201, 83378, 84233, 64708, 85041, and 84234, novel human guanine nucleotide dissociation stimulator, glycosyltransferase, dead type helicase, centaurin, dehydrogenase/reductase, and metal transporter family members and uses thereof |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040644A1 Agent imparting resistance to external stimuli |
| 05/23/2002 | WO2002040636A2 Modification of a plant disease resistance gene specificity and method for engineering altered specificity |
| 05/23/2002 | WO2002040633A2 Optimized antitrypsin expression in rice cell culture |
| 05/23/2002 | WO2002040632A2 Creation and identification of proteins having new dna binding specificities |
| 05/23/2002 | WO2002040629A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | WO2002040545A2 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point |
| 05/23/2002 | WO2002040544A2 Mutant human factor ix with an increased resistance to inhibition by heparin |
| 05/23/2002 | WO2002040543A1 Functional fragment of the lectine receptor |
| 05/23/2002 | WO2002040542A2 58569 and 50111, human anion exchange proteins and methods of use thereof |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040539A2 Gpcr-like protein and nucleic acids encoding same |
| 05/23/2002 | WO2002040538A2 Regulation of human nmda receptor |
| 05/23/2002 | WO2002040537A2 Analogues and derivatives of gastrin releasing peptide (grp) |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040534A1 Nucleotide and polypeptide sequences of kcna7, a mammalian voltage-gated potassium channel protein, and use thereof |
| 05/23/2002 | WO2002040532A1 A new polypeptide-prostatic gland specific membrane antigen 9 and the polynucleotide encoding it |
| 05/23/2002 | WO2002040531A1 Lapemis hardwicki short chain neurotoxin and gene encoding it |
| 05/23/2002 | WO2002040530A2 Mutant bcl-2 proteins and uses thereof |
| 05/23/2002 | WO2002040528A1 A method of producing non-natural silk by bombyx mori |
| 05/23/2002 | WO2002040526A1 A novel polypeptide-homo brain specific expressed protein 18.70 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040525A1 A novel polypeptide-homo zinc finger protein 18.92 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040524A1 A NOVEL POLYPEPTIDE-HOMO aFGF CONJUGATED FACTOR 10.78 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040522A1 A NOVEL POLYPEPTIDE-HOMO TRANSCRIPTION GROWTH REGULATORY FACTOR β ACTIVATION PROTEIN 14.08 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040521A1 A novel polypeptide-homo dna-dependent rna polymerase ac40 subunit inhibitor 9.68 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040518A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040516A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
| 05/23/2002 | WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 05/23/2002 | WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | WO2002040513A2 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein |
| 05/23/2002 | WO2002040512A2 Human beta-defensin-3 |
| 05/23/2002 | WO2002040511A2 Dna sequence and microcine from escherichia coli strain dsm 6601 |
| 05/23/2002 | WO2002040509A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | WO2002040506A2 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | WO2002040504A2 Sol-fusin: use of gp64-6his to catalyze membrane fusion |
| 05/23/2002 | WO2002040501A2 Membrane scaffold proteins |
| 05/23/2002 | WO2002040500A2 Method of prognosis and diagnosis of congestive heart failure |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040242A1 Electroprocessed collagen |
| 05/23/2002 | WO2002040063A1 Multipurpose packages for sterilised products or products to be sterilised |
| 05/23/2002 | WO2002040059A2 Methods and compositions for inducing cell-mediated immune responses |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002039923A2 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039813A1 Pd-1-lacking mouse and use thereof |